{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:51Z","timestamp":1759332951809},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To examine clinical outcomes following an initial trabeculectomy with mitomycin-C for secondary glaucoma associated with uveitis in Beh\u00e7et disease (BD) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Retrospective interventional case series.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>Twenty-two eyes in 18 patients with uveitic glaucoma (UG) associated with Beh\u00e7et disease who underwent an initial trabeculectomy with mitomycin-C between January 1996 and August 2014 were retrospectively reviewed. The main outcome measures were intraocular pressure (IOP) control, persistence of a filtering bleb, incidence of postoperative complications, and preopertaive and postoperative frequency of uveitic attacks. We analyzed persistence rates using Kaplan-Meier life tables based on 3 definitions of target IOP control (\u226421, \u226418, \u226415 mm Hg) and filtering bleb persistence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Result:<\/jats:title>\n            <jats:p>The persistence rates of postoperative IOP at \u226421, \u226418, and \u226415 mm Hg at 5 years after surgery were 76.1%, 71.5%, and 68.1%, respectively, whereas that of a filtering bleb was 54.4%. Hypotony as a postoperative complication was observed in 4 (18.2%) cases. No significant difference was observed between the preoperative and postoperative frequency of uveitic attacks (1.36\u00b11.15 vs. 0.95\u00b11.49 times\/y, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.16). There was 1 case in which recurrence of uveitis after surgery caused a loss of filtering bleb, which required a reoperation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>At 5 years after surgery, the persistence rate of postoperative IOP control (\u226421 mm Hg) was 76.1% and that of a filtering bleb was 54.4%. The frequency of uveitis recurrence did not significantly increase after surgery. Attention must be paid to avoid such recurrence to maintain the filtering bleb.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ijg.0000000000000665","type":"journal-article","created":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T15:19:05Z","timestamp":1491059945000},"page":"603-607","source":"Crossref","is-referenced-by-count":11,"title":["Initial Trabeculectomy With Mitomycin-C for Secondary Glaucoma-associated With Uveitis in Beh\u00e7et Disease Patients"],"prefix":"10.1097","volume":"26","author":[{"given":"Keiko","family":"Komae","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuko","family":"Takamoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Aihara","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ohtomo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Okinaga","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisae","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Fujino","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Japan Community Health Care Organization Tokyo Shinjuku Center, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshikatsu","family":"Kaburaki","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Tokyo School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","article-title":"Incidence of secondary glaucoma in Behcet\u2019s disease","volume":"13","author":"Elgin","year":"2004","journal-title":"J Glaucoma"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0021-5155(02)00549-X","article-title":"A clinical evaluation of uveitis-associated secondary glaucoma","volume":"46","author":"Takahashi","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","article-title":"Comparison of patients with Beh\u00e7et\u2019s disease in the 1980s and 1990s","volume":"111","author":"Yoshida","year":"2004","journal-title":"Ophthalmology"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0039-6257(87)90091-9","article-title":"Wound healing in glaucoma filtering surgery","volume":"32","author":"Skuta","year":"1987","journal-title":"Surv Ophthalmol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IJG.0b013e3182685167","article-title":"Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma","volume":"23","author":"Iwao","year":"2014","journal-title":"J Glaucoma"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/01.ijg.0000146624.31345.33","article-title":"Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behcet\u2019s disease: a retrospective cohort study","volume":"13","author":"Yalvac","year":"2004","journal-title":"J Glaucoma"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.ijg.0000243476.43837.d6","article-title":"Trabeculectomy with mitomycin-C in secondary glaucoma associated with Behcet\u2019s disease","volume":"16","author":"Elgin","year":"2007","journal-title":"J Glaucoma"},{"issue":"suppl 1","key":"R8-20230912","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3109\/09273948.2014.981547","article-title":"A major review: current aspects of ocular Beh\u00e7et\u2019s disease in Japan","volume":"23","author":"Namba","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0002-9394(14)78239-X","article-title":"Signs and symptoms of uveitis. I. Anterior uveitis","volume":"47","author":"Hogan","year":"1959","journal-title":"Am J Ophthalmol"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0161-6420(02)01739-6","article-title":"Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients","volume":"110","author":"Hu","year":"2003","journal-title":"Ophthalmology"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0039-6257(97)00006-4","article-title":"Glaucoma associated with uveitis","volume":"41","author":"Moorthy","year":"l997","journal-title":"Surv Ophthalmol"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00417-015-3204-y","article-title":"Long-term results of ab externo trabeculotomy for glaucoma secondary to chronic uveitis","volume":"254","author":"Bogomil","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/eye.2009.117","article-title":"Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis","volume":"23","author":"Kaburaki","year":"2009","journal-title":"Eye"},{"key":"R15-20230912","first-page":"477","article-title":"Aqueous humor dynamics in experimental iridocyclitis","volume":"28","author":"Toris","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-20230912","first-page":"119","article-title":"Cataract surgery and intraocular lens implantation in patients with Beh\u00e7et disease [in Japanese]","volume":"103","author":"Hiraoka","year":"1999","journal-title":"J Japanese Ophthalmol Soc"},{"key":"R17-20230912","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Beh\u00e7et\u2019s disease with refractory uveoretinitis","volume":"31","author":"Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/archophthalmol.2011.2698","article-title":"Multicenter study of infliximab for refractory uveoretinitis in Beh\u00e7et disease","volume":"130","author":"Okada","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000329190","article-title":"Clinical course before and after cataract and glaucoma surgery under systemic infliximab therapy in patients with Beh\u00e7et disease","volume":"2","author":"Nishida","year":"2011","journal-title":"Case Rep Ophthalmol"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s10384-010-0824-y","article-title":"Intraocular surgery in patients receiving infliximab therapy for Beh\u00e7et disease","volume":"54","author":"Sakai","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000338703","article-title":"Trabeculotomy in a Behcet\u2019s disease patient one week after infliximab administration","volume":"3","author":"Koike","year":"2012","journal-title":"Case Rep Ophthalmol"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00061198-201707000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T20:58:33Z","timestamp":1694552313000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00061198-201707000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0000000000000665","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}